{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T10:32:31Z","timestamp":1768645951554,"version":"3.49.0"},"reference-count":27,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":928,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Clin Pract"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1111\/ijcp.12103","type":"journal-article","created":{"date-parts":[[2013,2,15]],"date-time":"2013-02-15T09:46:24Z","timestamp":1360921584000},"page":"244-249","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Dexrazoxane efficacy for anthracycline extravasation: use in UK clinical practice"],"prefix":"10.1155","volume":"67","author":[{"given":"S.","family":"Muthuramalingam","sequence":"first","affiliation":[{"name":"Queen Alexandra Hospital; Portsmouth UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Gale","sequence":"additional","affiliation":[{"name":"Queen Alexandra Hospital; Portsmouth UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Bradbury","sequence":"additional","affiliation":[{"name":"Queen Alexandra Hospital; Portsmouth UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,2,15]]},"reference":[{"issue":"17","key":"10.1111\/ijcp.12103-BIB0001|ijcp12103-cit-0001","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.12968\/bjon.2011.20.Sup10.S16","article-title":"Anthracycline extravasations require prompt and effective management to improve patient care","volume":"20","author":"Roe","year":"2011","journal-title":"Br J Nurs"},{"key":"10.1111\/ijcp.12103-BIB0002|ijcp12103-cit-0002","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/01.NAJ.0000282299.03441.c7","article-title":"Infiltration and extravasation","volume":"107","author":"Hadaway","year":"2007","journal-title":"Am J Nurs"},{"key":"10.1111\/ijcp.12103-BIB0003|ijcp12103-cit-0003","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2147\/TCRM.S3694","article-title":"Anthracycline extravasation injuries: management with dexrazoxane","volume":"5","author":"Jordan","year":"2009","journal-title":"Ther Clin Risk Manag"},{"key":"10.1111\/ijcp.12103-BIB0004|ijcp12103-cit-0004","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/030089160909500301","article-title":"Anthracycline extravasation: a comprehensive review of experimental and clinical treatments","volume":"95","author":"Langer","year":"2009","journal-title":"Tumori"},{"issue":"4 Suppl. Nurse","key":"10.1111\/ijcp.12103-BIB0005|ijcp12103-cit-0005","first-page":"34","article-title":"Vesicant extravasation from an implanted venous access port","volume":"23","author":"Wickham","year":"2009","journal-title":"Oncology (Williston Park)"},{"key":"10.1111\/ijcp.12103-BIB0006|ijcp12103-cit-0006","unstructured":"EONS (European Oncology Nursing Society) Extravasation guidelines 2007: Guidelines, Implementation Toolkit pg 1-42 www.cancernurse.eu\/documents\/EONSClinicalGuidelinesSection6-en.pdf"},{"key":"10.1111\/ijcp.12103-BIB0007|ijcp12103-cit-0007","volume-title":"UKONS anthracycline extravasation management guidelines","author":"United Kingdom Oncology Nursing Society","year":"2008"},{"key":"10.1111\/ijcp.12103-BIB0008|ijcp12103-cit-0008","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ejon.2008.07.003","article-title":"European Oncology Nursing Society extravasation guidelines","volume":"12","author":"Wengstr\u00f6m","year":"2008","journal-title":"Eur J Oncol Nurs"},{"key":"10.1111\/ijcp.12103-BIB0009|ijcp12103-cit-0009","volume-title":"Chemotherapy and Biotherapy Guidelines and Recommendations for Practice","author":"Polovich","year":"2009","edition":"3"},{"key":"10.1111\/ijcp.12103-BIB0010|ijcp12103-cit-0010","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.soncn.2010.11.010","article-title":"Extravasation management: clinical update","volume":"27","author":"Schulmeister","year":"2011","journal-title":"Semin Oncol Nurs"},{"key":"10.1111\/ijcp.12103-BIB0011|ijcp12103-cit-0011","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1517\/13543784.17.2.217","article-title":"The use of dexrazoxane for the prevention of anthracycline extravasation injury","volume":"17","author":"Hasinoff","year":"2008","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1111\/ijcp.12103-BIB0012|ijcp12103-cit-0012","first-page":"8","article-title":"Dietary topoisomerase II-poisons: contribution of soy products to infant leukemia?","volume":"1","author":"Hengstler","year":"2002","journal-title":"EXCLI J"},{"key":"10.1111\/ijcp.12103-BIB0013|ijcp12103-cit-0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/0929867305666220314194045","article-title":"Chemical, biological and clinical aspects of dexrazoxane and other bisdioxopiperazines","volume":"5","author":"Hasinoff","year":"1998","journal-title":"Curr Med Chem"},{"key":"10.1111\/ijcp.12103-BIB0014|ijcp12103-cit-0014","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0006-2952(97)00116-0","article-title":"DNA topoisomerase II rescue by catalytic inhibitors","volume":"54","author":"Jensen","year":"1997","journal-title":"Biochem Pharmacol"},{"key":"10.1111\/ijcp.12103-BIB0015|ijcp12103-cit-0015","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/annonc\/mdl413","article-title":"Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies","volume":"18","author":"Mouridsen","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1111\/ijcp.12103-BIB0016|ijcp12103-cit-0016","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/CAD.0b013e32833d9032","article-title":"Mateu-de Antonio J. Successful dexrazoxane treatment of a potentially severe extravasation of concentrated doxorubicin","volume":"21","author":"Conde-Est\u00e9vez","year":"2010","journal-title":"Anticancer Drugs"},{"key":"10.1111\/ijcp.12103-BIB0017|ijcp12103-cit-0017","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1345\/aph.1M636","article-title":"Successful experience utilizing dexrazoxane treatment for an anthracycline extravasation","volume":"44","author":"Tyson","year":"2010","journal-title":"Ann Pharmacother"},{"issue":"5","key":"10.1111\/ijcp.12103-BIB0018|ijcp12103-cit-0018","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00520-012-1382-2","article-title":"Savene\u00ae (dexrazoxane) use in clinical practice","volume":"20","author":"Fontaine","year":"2012","journal-title":"Support Care Cancer"},{"key":"10.1111\/ijcp.12103-BIB0019|ijcp12103-cit-0019","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s10147-006-0598-x","article-title":"Intrapleural extravasation of epirubicin, 5-fluouracil, and cyclophosphamide, treated with dexrazoxane","volume":"11","author":"Uges","year":"2006","journal-title":"Int J Clin Oncol."},{"key":"10.1111\/ijcp.12103-BIB0020|ijcp12103-cit-0020","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S1470-2045(04)01470-6","article-title":"Dexrazoxane for anthracycline extravasation and GM-CSF for skin ulceration and wound healing","volume":"5","author":"El-Saghir","year":"2004","journal-title":"Lancet Oncol"},{"key":"10.1111\/ijcp.12103-BIB0021|ijcp12103-cit-0021","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/02844310310007791","article-title":"Dexrazoxane-a promising antidote in the treatment of accidental extravasation of anthracyclines","volume":"37","author":"Jensen","year":"2003","journal-title":"Scand J Plast Reconstr Surg Hand Surg"},{"key":"10.1111\/ijcp.12103-BIB0022|ijcp12103-cit-0022","first-page":"3064","article-title":"Dexrazoxane in anthracycline extravasation","volume":"18","author":"Langer","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1111\/ijcp.12103-BIB0023|ijcp12103-cit-0023","unstructured":"SpePharm Data on File"},{"key":"10.1111\/ijcp.12103-BIB0024|ijcp12103-cit-0024","unstructured":"Savene \u00ae Summary of Product Characteristics - July 2012"},{"key":"10.1111\/ijcp.12103-BIB0025|ijcp12103-cit-0025","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00280-005-0022-7","article-title":"Treatment of anthracycline extravasation in mice with dexrazoxane with or without DMSO and hydrocortisone","volume":"57","author":"Langer","year":"2006","journal-title":"Treatment of Cancer Chemother Pharmacol"},{"key":"10.1111\/ijcp.12103-BIB0026|ijcp12103-cit-0026","volume-title":"The MASCC Textbook of Cancer Supportive Care and Survivorship","author":"Schulmeister","year":"2011"},{"key":"10.1111\/ijcp.12103-BIB0027|ijcp12103-cit-0027","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1634\/theoncologist.2007-0247","article-title":"Dexrazoxane (Totect): FDA review and approval for the treatment of accidental extravasation following intravenous anthracycline chemotherapy","volume":"13","author":"Kane","year":"2008","journal-title":"Oncologist."}],"updated-by":[{"DOI":"10.1111\/ijcp.12237","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2013,7,22]],"date-time":"2013-07-22T00:00:00Z","timestamp":1374451200000}}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fijcp.12103","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T15:17:18Z","timestamp":1688051838000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ijcp.12103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,15]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"URL":"https:\/\/doi.org\/10.1111\/ijcp.12103","relation":{"correction":[{"id-type":"doi","id":"10.1111\/ijcp.12237","asserted-by":"object"}]},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2,15]]},"assertion":[{"value":"2013-02-15","name":"published_online","label":"Published Online","group":{"name":"publication_history","label":"Publication History"}}]}}